SPL 9.20% 9.5¢ starpharma holdings limited

“…to present the results from the phase I/II study…” Not...

  1. 1,787 Posts.
    lightbulb Created with Sketch. 315
    “…to present the results from the phase I/II study…”

    Not “intermediate results”, just “results”

    Looks like the Irinotecan trial has finally been concluded (even though treatment may still be ongoing). Let’s see what the quarterly report has to say later today or tomorrow.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.